XUCS:F:F-Xtrackers (IE) Public Limited Company - Xtrackers MSCI USA Consumer Staples UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 42.53

Change

+0.19 (+0.44)%

Market Cap

USD 0.09B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.13 (+0.47%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.04 (+0.09%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.50 (+0.21%)

USD 53.24B
VUSA:F Vanguard Funds Public Limited ..

+0.27 (+0.28%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.51 (-0.53%)

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.08 (+0.52%)

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.09B
0ZC:F Zscaler Inc

+0.08 (+0.05%)

USD 37.92B

ETFs Containing XUCS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.95% 85% B 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.95% 82% B 67% D+
Trailing 12 Months  
Capital Gain 11.92% 59% D- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.92% 55% F 56% F
Trailing 5 Years  
Capital Gain 40.99% 67% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.99% 67% D+ 55% F
Average Annual (5 Year Horizon)  
Capital Gain 7.08% 64% D 64% D
Dividend Return 7.08% 61% D- 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.40% 64% D 87% B+
Risk Adjusted Return 68.08% 79% B- 83% B
Market Capitalization 0.09B 25% F 30% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.